Campagnolo A.M., Priston J., Thoen R.H., Medeiros T., Assunção A.R. Laryngopharyngeal reflux: diagnosis, treatment, and latest research Int Arch Otorhinolaryngol. 2014;18(2):184–191. https://doi.org/10.1055/s-0033-1352504..
DOI: 10.1055/s-0033-1352504
Ford C.N. Evaluation and management of laryngopharyngeal reflux. JAMA. 2005;294(12):1534–1540. https://doi.org/10.1001/jama.294.12.1534..
DOI: 10.1001/jama.294.12.1534
Hom C., Vaezi M.F. Extra-esophageal Manifestations of Gastroesophageal Reflux Disease: Diagnosis and Treatment. Drugs. 2013;73(12):1281–1295. https://doi.org/10.1007/s40265-013-0101-8..
DOI: 10.1007/s40265-013-0101-8
Wang J., Yu Z., Ren J., Xu Y., Zhang Y., Lei L. et al. Effects of pepsin A on heat shock protein 70 response in laryngopharyngeal reflux patients with chronic rhinosinusitis. Acta Otolaryngologica. 2017;137(12):848–854. https://doi.org/10.1080/00016489.2017.1360515..
DOI: 10.1080/00016489.2017.1360515
Koufman J.A., Aviv J.E., Casiano R.R., Shaw G.Y. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology–Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;(127)32–35. https://doi.org/10.1067/mhn.2002.125760..
DOI: 10.1067/mhn.2002.125760
Weijenborg P.W., Savarino E., Kessing B.F., Roman S., Costantini M., Oors J.M. et al. Normal values of esophageal motility after antireflux surgery; a study using high-resolution manometry. Neurogastroenterol Motil. 2015;27(7):929–935. https://doi.org/10.1111/nmo.12554..
DOI: 10.1111/nmo.12554
Dhillon V.K., Akst L.M. How to Approach Laryngopharyngeal Reflux: An Otolaryngology Perspective. Curr Gastroenterol Rep. 2016;18(8):44. https://doi.org/10.1007/s11894-016-0515-z..
DOI: 10.1007/s11894-016-0515-z
Савлевич Е.Л., Козлов В.С., Анготоева И.Б. Современные представления о роли небных миндалин в системе иммунитета и анализ применения иммунотропных препаратов при хроническом тонзиллите. Российская оториноларингология. 2018;(6):48–55. Режим доступа: https://entru.org/files/j_rus_LOR_6_2018.pdf.https://entru.org/files/j_rus_LOR_6_2018.pdf
Савлевич Е.Л., Козлов В.С., Анготоева И.Б. Современные представления о роли небных миндалин в системе иммунитета и анализ применения иммунотропных препаратов при хроническом тонзиллите. Российская оториноларингология. 2018;(6):48–55. Режим доступа: https://entru.org/files/j_rus_LOR_6_2018.pdf.https://entru.org/files/j_rus_LOR_6_2018.pdf
Lechien J.R., Saussez S., Schindler A., Karkos P.D., Hamdan A.L., Harmegnies B. et al. Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis. Laryngoscope. 2019;129(5):1174–1187. https://doi.org/10.1002/lary.27591..
DOI: 10.1002/lary.27591
Lechien J.R., Mouawad F., Barillari M.R., Nacci A., Khoddami S.M., Nand E. et al. Treatment of laryngopharyngeal reflux disease: A systematic review. World J Clin Cases. 2019;7(19):2995–3011. https://doi.org/10.12998/wjcc.v7.i19.2995..
DOI: 10.12998/wjcc.v7.i19.2995
Francis D.O. Bench to trench: how evidence and guidelines shape health care policy and practice. Otolaryngol Head Neck Surg. 2013;149(3):356–359. https://doi.org/10.1177/0194599813491228..
DOI: 10.1177/0194599813491228
Lechien J.R., Dapri G., Dequanter D., Rodriguez Ruiz A., Marechal M.T., De Marrez L.G. et al. Surgical Treatment for Laryngopharyngeal Reflux Disease: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019;145(7):655–666. https://doi.org/10.1001/jamaoto.2019.0315..
DOI: 10.1001/jamaoto.2019.0315
Danielson P.B. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab. 2002;3(6):561–597. https://doi.org/10.2174/1389200023337054..
DOI: 10.2174/1389200023337054
Lima J.J., Thomas C.D., Barbarino J., Desta Z., Van Driest S.L., El Rouby N. et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. Clin Pharmacol Ther. 2021;109(6):1417–1423. https://doi.org/10.1002/cpt.2015..
DOI: 10.1002/cpt.2015
Sim S.C., Risinger C., Dahl M.L., Aklillu E., Christensen M., Bertilsson L., Ingelman-Sundberg M. A сommon novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther. 2006;79(1):103–113. https://doi.org/10.1016/j.clpt.2005.10.002..
DOI: 10.1016/j.clpt.2005.10.002
Klotz U., Schwab M., Treiber G. CYP2C19 polymorphism and proton pump inhibitors. Basic Clin Pharmacol Toxicol. 2004;95(1):2–8. https://doi.org/10.1111/j.1600-0773.2004.pto950102.x..
DOI: 10.1111/j.1600-0773.2004.pto950102.x
Yang J.C., Lin C.J. CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection. Expert Opin Drug Metab Toxicol. 2010;6(1):29–41. https://doi.org/10.1517/17425250903386251..
DOI: 10.1517/17425250903386251
Леонова М.В. Фармакогенетика ингибиторов протонной помпы. Медицинский совет. 2015;(17):96–103. https://doi.org/10.21518/2079-701X-2015-17-96-103..
DOI: 10.21518/2079-701X-2015-17-96-103
Koufman J.A. The otolaryngologic manifestation of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;10(2 Suppl.):1–78. https://doi.org/10.1002/lary.1991.101.s53.1..
DOI: 10.1002/lary.1991.101.s53.1
Belafsky P.C., Postma G.N., Koufman J.A. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope. 2001;111(6):979–981. https://doi.org/10.1097/00005537-200106000-00009..
DOI: 10.1097/00005537-200106000-00009
Belafsky P.C., Postma G.N., Koufman J.A. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16(2):274–277. https://doi.org/10.1016/s0892-1997(02)00097-8..
DOI: 10.1016/s0892-1997(02)00097-8
Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., Festen H.P., Jansen E.H., Tuynman H.A. et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 1997;92(11):1997–2000. Available at: https://pubmed.ncbi.nlm.nih.gov/9362179.https://pubmed.ncbi.nlm.nih.gov/9362179
Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., Festen H.P., Jansen E.H., Tuynman H.A. et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 1997;92(11):1997–2000. Available at: https://pubmed.ncbi.nlm.nih.gov/9362179.https://pubmed.ncbi.nlm.nih.gov/9362179
Сычев Д.А., Шпрах В.В., Китаева Е.Ю., Мирзаев К.Б., Михалевич И.М. Генетические и негенетические факторы лабораторной резистентности к клопидогрелу у больных с ишемическим инсультом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;(3–2):45–52. https://doi.org/10.17116/jnevro201911903245..
DOI: 10.17116/jnevro201911903245
Sibbing D., Gebhard D., Koch W., Braun S., Stegherr J., Morath T. et al. Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. J Thromb Haemost. 2010;8(8):1685–1693. https://doi.org/10.1111/j.1538-7836.2010.03921.x..
DOI: 10.1111/j.1538-7836.2010.03921.x
Mega J., Close S., Wiviott S., Shen L., Hockett R.D., Brandt J.T. et al. Cytochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360(4):354–624. https://doi.org/10.1056/NEJMoa0809171..
DOI: 10.1056/NEJMoa0809171
Luo H.R., Poland R.E., Lin K.M., Wan Y.J. Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study. Clin Pharmacol Ther. 2006;80(1):33–40. https://doi.org/10.1016/j.clpt.2006.03.003..
DOI: 10.1016/j.clpt.2006.03.003
Giusti B., Gori A.M., Marcucci R., Saracini C., Sestini I., Paniccia R. et al. Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drugeluting coronary stent thrombosis. Am J Cardiol. 2009;103(6):806–811. https://doi.org/10.1016/j.amjcard.2008.11.048..
DOI: 10.1016/j.amjcard.2008.11.048
Bonello L., Armero S., Ait Mokhtar O., Mancini J., Aldebert P., Saut N. et al. Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism. J Am Coll Cardiol. 2010;56(20):1630–1636. https://doi.org/10.1016/j.jacc.2010.07.004..
DOI: 10.1016/j.jacc.2010.07.004
Мирзаев К.Б., Сычев Д.А., Каркищенко В.Н., Грачев А.В., Князева Г.П., Казаков Р.Е., Карасев А.В. Частота полиморфных маркеров CYP2C19*2, CYP2C19*3, CYP2C19*17 среди русской популяции и сравнение распространенности CYP2C19*2 у пациентов с ишемической болезнью сердца, получающих клопидогрел, и здоровых добровольцев. Биомедицина. 2013;(1):117–121. Режим доступа: https://journal.scbmt.ru/jour/article/viewFile/248/153.https://journal.scbmt.ru/jour/article/viewFile/248/153
Мирзаев К.Б., Сычев Д.А., Каркищенко В.Н., Грачев А.В., Князева Г.П., Казаков Р.Е., Карасев А.В. Частота полиморфных маркеров CYP2C19*2, CYP2C19*3, CYP2C19*17 среди русской популяции и сравнение распространенности CYP2C19*2 у пациентов с ишемической болезнью сердца, получающих клопидогрел, и здоровых добровольцев. Биомедицина. 2013;(1):117–121. Режим доступа: https://journal.scbmt.ru/jour/article/viewFile/248/153.https://journal.scbmt.ru/jour/article/viewFile/248/153
Powell J., O’Hara J., Wilson J.A. Are persistent throat symptoms atypical features of gastric reflux and should they be treated with proton pump inhibitors? BMJ. 2014;349:g5813. https://doi.org/10.1136/bmj.g5813..
DOI: 10.1136/bmj.g5813
Kowalik K., Krzeski A. The role of pepsin in the laryngopharyngeal reflux. Otolaryngol Pol. 2017;71(6):7–13. https://doi.org/10.5604/01.3001.0010.7194..
DOI: 10.5604/01.3001.0010.7194
Adhami T., Goldblum J.R., Richter J.E., Vaezi M.F. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol. 2004;99(11):2098–2106. Available at: https://pubmed.ncbi.nlm.nih.gov/15554987.https://pubmed.ncbi.nlm.nih.gov/15554987
Adhami T., Goldblum J.R., Richter J.E., Vaezi M.F. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol. 2004;99(11):2098–2106. Available at: https://pubmed.ncbi.nlm.nih.gov/15554987.https://pubmed.ncbi.nlm.nih.gov/15554987
Loughlin C.J., Koufman J.A., Averill D.B., Cummins M.M., Kim Y.J., Little J.P. et al. Acid-induced laryngospasm in a canine model. Laryngoscope.1996;106(12): 1506–1509. https://doi.org/10.1097/00005537-199612000-00012..
DOI: 10.1097/00005537-199612000-00012
Franco R.A. Laryngopharyngeal Reflux. UpToDate. 2017. Available at: https://uptodatefree.ir/topic.htm?path=laryngopharyngeal-reflux.https://uptodatefree.ir/topic.htm?path=laryngopharyngeal-reflux
Franco R.A. Laryngopharyngeal Reflux. UpToDate. 2017. Available at: https://uptodatefree.ir/topic.htm?path=laryngopharyngeal-reflux.https://uptodatefree.ir/topic.htm?path=laryngopharyngeal-reflux
Bove M.J., Rosen C. Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):116–123. Available at: https://pubmed.ncbi.nlm.nih.gov/16728885.https://pubmed.ncbi.nlm.nih.gov/16728885
Bove M.J., Rosen C. Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):116–123. Available at: https://pubmed.ncbi.nlm.nih.gov/16728885.https://pubmed.ncbi.nlm.nih.gov/16728885
Блюме Х., Донат Ф., Варнке А., Шуг Б.С. Фармакокинетические лекарственные взаимодействия с участием ингибиторов протонной помпы. РМЖ. 2009;(9):622. Режим доступа: https://www.rmj.ru/articles/gastroenterologiya/Farmakokineticheskie_lekarstvennye_vzaimodeystviya s_uchastiem_ingibitorov_protonnoy_pompy.https://www.rmj.ru/articles/gastroenterologiya/Farmakokineticheskie_lekarstvennye_vzaimodeystviya
Блюме Х., Донат Ф., Варнке А., Шуг Б.С. Фармакокинетические лекарственные взаимодействия с участием ингибиторов протонной помпы. РМЖ. 2009;(9):622. Режим доступа: https://www.rmj.ru/articles/gastroenterologiya/Farmakokineticheskie_lekarstvennye_vzaimodeystviya s_uchastiem_ingibitorov_protonnoy_pompy.https://www.rmj.ru/articles/gastroenterologiya/Farmakokineticheskie_lekarstvennye_vzaimodeystviya
Pinto-Sanchez M., Yuan Y., Hassan A., Bercik P., Moayyedi P. Proton pump inhibitors for functional dyspepsia. Cochrane Database of Systematic Reviews. 21;11(11):CD011194. https://doi.org/10.1002/14651858.CD011194.pub3..
DOI: 10.1002/14651858.CD011194.pub3